NextBio

Help
Description: A sulfone active against a wide range of bacteria but mainly employed for its actions against mycobacterium leprae. Its mechanism of action is probably similar to that of the sulfonamides which involves inhibition of folic acid synthesis in susceptible organisms. It is also used with pyrimethamine in the treatment of malaria. (From Martindale, The Extra Pharmacopoeia, 30th ed, p157-8)
Drug Type: Small Molecule; Approved; Investigational
Pharmacology: Dapsone is a sulfone with anti-inflammatory immunosuppressive properties as well as antibacterial and antibiotic properties. Dapsone is the principal drug in a multidrug regimen recommended by the World Health Organization for the treatment of leprosy. As an anti-infective agent, it is also used for treating malaria and, recently, for Pneumocystic carinii pneumonia in AIDS patients. Dapsone is absorbed rapidly and nearly completely from the gastrointestinal tract. Dapsone is distributed throughout total body water and is present in all tissues. However, it tends to be retained in skin and muscle and especially in the liver and kidney: traces of the drug are present in these organs up to 3 weeks after therapy cessation.
Mechanism of Action: Dapsone acts against bacteria and protozoa in the same way as sulphonamides, that is by inhibiting the synthesis of dihydrofolic acid through competition with para-amino-benzoate for the active site of dihydropteroate synthetase. The anti-inflammatory action of the drug is unrelated to its antibacterial action and is still not fully understood.
Indication: For the treatment and management of leprosy and dermatitis herpetiformis.
Half Life: 28 hours (range 10-50 hours)
View Complete Description




Individual Studies
  • Peripheral neuropathies from PMP22 mutants

    Mus musculus Mus musculus | RNA Expression   RNA Expression

    We compared gene expression at ages P4 and P60 in sciatic nerve of wild type mice and mice with peripheral neuropathies caused by altered Pmp22 gene dosage (homozygous knockout or transgene) or a point mutation (Trembler).

    Authors: Giambonini-Brugnoli G, Buchstaller J, Sommer L et al.

    Organization: Swiss Federal Institute of Technology In…

  • Drug-Induced Renal Tubular Toxicity

    Rattus norvegicus Rattus norvegicus | RNA Expression   RNA Expression

    These data support the publication titled "A Gene Expression Signature that Predicts the Future Onset of Drug-Induced Renal Tubular Toxicity"

    Authors: Fielden MR, Eynon BP, Natsoulis G et al.

    Organization: Iconix Pharmaceuticals 325 E Middlefield…

View All Individual Studies

Thought leaders and organizations working on research involving Dapsone.

  • Piyush M Vyas
  • Camilo RĂ­os
  • Timothy S Tracy
  • Sanjoy Roychowdhury
  • Craig K Svensson
  • National Institute of Allergy and Infectious Diseases (NIAID)
  • Allergan
  • Jacobus Pharmaceutical
  • Gilead Sciences
  • Gates Malaria Partnership
  • London School of Hygiene and Tropical Medicine
  • University of Minnesota
  • University of Iowa
  • Wayne State University
  • University of California, San Francisco

Clinical Trials | 162 trials

Help for Clinical Trials View All

Community

Help for Community
  • No NextBio users were found for “Dapsone”.
    Complete your user profile with your interests, if you want others to find you within the NextBio community.

  • No NextBio groups were found for “Dapsone”.
    Be the first to start a group and share your interests with others within the NextBio community.